CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer

Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2

(2011) Tú Nguyen-Dumont et al.   BMC Medical Genomics

Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes

(2011) Jord H. A. Nagel et al.   BREAST CANCER RESEARCH AND TREATMENT

Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility

(2011) He-ping Xiang et al.   EUROPEAN JOURNAL OF CANCER

Gene–gene interactions in breast cancer susceptibility

(2011) Clare Turnbull et al.   HUMAN MOLECULAR GENETICS

CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women

(2011) M. A. Adank et al.   JOURNAL OF MEDICAL GENETICS

Prevalence of the variant allele rs61764370 T>G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families

(2010) Antoinette Hollestelle et al.   BREAST CANCER RESEARCH AND TREATMENT

A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer

(2010) Shuyu Zhang et al.   CARCINOGENESIS

Discovering moderate-risk breast cancer susceptibility genes

(2010) Antoinette Hollestelle et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Evaluating Cancer Epidemiologic Risk Factors Using Multiple Primary Malignancies

(2010) Ekatherina Kuligina et al.   EPIDEMIOLOGY

Genetics of lung-cancer susceptibility

(2010) Paul Brennan et al.   LANCET ONCOLOGY

The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype–phenotype correlations

(2009) Janet Hall et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Family History, Genetic Testing, and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1,828 Bilateral Breast Cancers and 7,030 Controls

(2009) O. Fletcher et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types

(2009) Thorunn Rafnar et al.   NATURE GENETICS

Mice with the CHEK2*1100delC SNP are predisposed to cancer with a strong gender bias

(2009) E. M. Bahassi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study

(2008) L Mellemkjær et al.   BRITISH JOURNAL OF CANCER

Frequency of the CHEK2 1100delC Mutation among Women with Breast Cancer: An International Study

(2008) S. Zhang et al.   CANCER RESEARCH

Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers

(2008) C. Cybulski et al.   CARCINOGENESIS

CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls

(2008) Maren Weischer et al.   JOURNAL OF CLINICAL ONCOLOGY

Common variants of DNA repair genes and malignant melanoma

(2007) T. Dębniak et al.   EUROPEAN JOURNAL OF CANCER

Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?

(2007) Olga Anczuków et al.   HUMAN MUTATION